Aaron Berger, MD, discussed updates in the treatment of non-metastatic castration-resistant prostate cancer.
The Exablate Prostate system, guided by MRI technology, directs sound waves toward cancerous prostate tissue, destroying only the malignant tissue and preserving the healthy structures nearby.
It’s the third cancer risk test from the company.
Participants in the yoga group had enhanced physical, social, and functional well-being, and improved symptoms of fatigue and stress.
View this presentation by Robert E. Reiter, MD, during the 31st International Prostate Cancer Update in July 2021 in Snowbird, Utah.